biotech news today obesity drugs glp-1 Weight loss without side effects? Top researchers propose new approach Three obesity drugs. Three mechanisms.

Ozempic may contribute to an increased risk for thyroid c-cell tumors, acute pancreatitis, gallbladder disease, hypoglyceia, acute kidney injury, severe GI side effects, and an increased risk for worsening of diabetic retinopathy in people with type 2 diabetes

Image source: GLP-1s and Food Noise One of the interesting impacts of the GLP1 medications is the reduction of what is called food noise, also known as food-related intrusive thoughts or food preoccupation (Mozafariun 2025)

GLP-1 receptor agonists are FDA-approved for type 2 diabetes and obesity, not autoimmune conditions

The combination of slower gastric emptying + smaller meals + the same alcohol volume = faster intoxication and worse nausea

The distinction between adaptive and maladaptive muscle loss is central to understanding the quality, not just the quantity, of BW loss achieved with GLP-1 RA-based therapies [37, 38]

Is there a refund, exchange, or error policy if shipping or compounding issues arise